Literature DB >> 29605809

Success stories of natural product-based hybrid molecules for multi-factorial diseases.

Shalki Choudhary1, Pankaj Kumar Singh1, Himanshu Verma1, Harpreet Singh2, Om Silakari3.   

Abstract

Complex diseases comprises of highly complicated etiology resulting in limited applicability of conventional targeted therapies. Consequently, conventional medicinal compounds suffer major failure when used for such disease conditions. Additionally, development of multidrug resistance (MDR), adverse drug reactions and clinical specificity of single targeted drug therapy has increased thrust for novel drug therapy. In this rapidly evolving era, natural product-based discovery of hybrid molecules or multi-targeted drug therapies have shown promising results and are trending now a days. Historically, nature has blessed human with different sources viz. plant, animal, microbial, marine and ethnopharmaceutical sources which has given a wide variety of medicinally active compounds. These compounds from natural origin are always choice of interest of medicinal chemists because of their minimum side effects. Hybrid molecules synthesized by fusing or conjugating different active molecules obtained from these sources are reported to synergistically block different pathways which contribute in the pathogenesis of complex diseases. This review strives to encompass all natural product-derived hybrid molecules which act as multi-targeting agents striking various targets involved in different pathways of complex diseased conditions reported in literature.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Complex disease; Hybrid; Multi-targeted; Natural products

Mesh:

Substances:

Year:  2018        PMID: 29605809     DOI: 10.1016/j.ejmech.2018.03.057

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  12 in total

Review 1.  Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs.

Authors:  Soon Yong Park; Hyeongrok Choi; Jin Woong Chung
Journal:  Pharmaceutics       Date:  2022-04-16       Impact factor: 6.525

2.  Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.

Authors:  Leili Jalili-Baleh; Hamid Nadri; Hamid Forootanfar; Tuba Tüylü Küçükkılınç; Beyza Ayazgök; Mohammad Sharifzadeh; Mahban Rahimifard; Maryam Baeeri; Mohammad Abdollahi; Alireza Foroumadi; Mehdi Khoobi
Journal:  Daru       Date:  2021-01-09       Impact factor: 3.117

3.  Innovative C2-symmetric testosterone and androstenedione dimers: Design, synthesis, biological evaluation on prostate cancer cell lines and binding study to recombinant CYP3A4.

Authors:  Alexis Paquin; Yassine Oufqir; Irina F Sevrioukova; Carlos Reyes-Moreno; Gervais Bérubé
Journal:  Eur J Med Chem       Date:  2021-04-24       Impact factor: 7.088

4.  Design, synthesis and in silico screening of benzoxazole-thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases.

Authors:  Vijay Sai Krishna Cheerala; Prasanth Ghanta; Sundaresan Chittor Neelakantan
Journal:  RSC Adv       Date:  2021-12-10       Impact factor: 4.036

Review 5.  Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.

Authors:  Vuyolwethu Khwaza; Sithenkosi Mlala; Opeoluwa O Oyedeji; Blessing A Aderibigbe
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

Review 6.  Development of Phenothiazine Hybrids with Potential Medicinal Interest: A Review.

Authors:  Marina C Posso; Fernanda C Domingues; Susana Ferreira; Samuel Silvestre
Journal:  Molecules       Date:  2022-01-03       Impact factor: 4.411

7.  Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity.

Authors:  Min Dong; Guili Zheng; Feng Gao; Min Li; Chen Zhong
Journal:  Front Pharmacol       Date:  2022-01-26       Impact factor: 5.810

8.  A bio-inspired synthesis of hybrid flavonoids from 2-hydroxychalcone driven by visible light.

Authors:  Yu-Qi Gao; Yi Hou; Liming Zhu; Guzhou Chen; Dongyang Xu; Sheng-Yong Zhang; Yupeng He; Weiqing Xie
Journal:  RSC Adv       Date:  2019-09-16       Impact factor: 4.036

9.  Identification of Natural Compounds against Neurodegenerative Diseases Using In Silico Techniques.

Authors:  Larisa Ivanova; Mati Karelson; Dimitar A Dobchev
Journal:  Molecules       Date:  2018-07-25       Impact factor: 4.411

10.  Betulinic Acid-Azaprostanoid Hybrids: Synthesis and Pharmacological Evaluation as Anti-inflammatory Agents.

Authors:  Tatyana S Khlebnicova; Yuri A Piven; Fedor A Lakhvich; Iryna V Sorokina; Tatiana S Frolova; Dmitry S Baev; Tatyana G Tolstikova
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.